Bridgefront Capital’s Repligen RGEN Stock Holding History

Bridgefront Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$402K	Buy	+3,409	New	+$476K	0.1%	316
2025 Q1	–	Sell	-3,904	Closed	-$562K	–	810
2024 Q4	$562K	Buy	+3,904	New	+$560K	0.19%	170
2022 Q3	–	Sell	-2,253	Closed	-$366K	–	440
2022 Q2	$366K	Buy	+2,253	New	+$356K	0.41%	84
2022 Q1	–	Sell	-822	Closed	-$218K	–	399
2021 Q4	$218K	Buy	+822	New	+$221K	0.21%	222
2021 Q2	–	Sell	-1,194	Closed	-$232K	–	854
2021 Q1	$232K	Buy	+1,194	New	+$245K	0.07%	521

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bridgefront Capital's RGEN Position: Q1 2026 in Review

Bridgefront Capital opened a new position in Repligen (RGEN) in Q1 2026: 3,409 shares worth $402K. The stake represents 0.1% of the portfolio and ranks #316 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in RGEN as recently as Q4 2024.

Bridgefront Capital first reported a position in RGEN in Q1 2021 and has held it in 5 quarters since. The position peaked at $562K in Q4 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Bridgefront Capital held 3,409 shares of Repligen worth $402K as of Q1 2026.
Repligen was a new Bridgefront Capital position in Q1 2026.
Repligen made up 0.1% of Bridgefront Capital's portfolio in Q1 2026, its #316 holding.
Bridgefront Capital first reported a position in Repligen in Q1 2021 and has held it in 5 quarters since.
Bridgefront Capital's Repligen position peaked at $562K in Q4 2024.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.